I would welcome that cooperation as we move forward.
It isn't as if there's a short supply, there's a manufacturing problem, the FDA comes in, offers friendly advice, the pr...
So there really is a need for some kind of fact-finding here on a broader basis than just an individual finding of a par...
I would like to have an opportunity for my staff to contact you and verify those numbers.
There has been no real investigation. That's the very simple answer to a doctor, talking to you as a former attorney gen...
I just want to suggest, and you should feel free to disagree, that at the very minimum there ought to be a ban on any se...
Don't you think that there is a need for an investigation here by the FTC or the Department of Justice in light of these...
The shortages are creating a public health menace, and the anti-consumer practices clearly promote a gray market.
We ought to have zero tolerance for this kind of profiteering and price gouging, and we ought to do whatever is necessar...
This market is simply not working. It cannot be allowed to continue in the dysfunctional fashion that it is right now.
I think that much more drastic and far-reaching and aggressive measures are necessary than have been proposed.
I get a lot more comfortable on this stuff, on these ideas, if the investors who are purchasing these securities underst...
Look, we get things done in this committee, and we do get things done in this committee because we are factual and we le...
I am really hopeful we are going to get something done here in good bipartisan fashion.
I am an original cosponsor of the legislation that we are here to talk about, so I am very excited about it.
I come from a insurance capital of the world, and--we like to think--and also--so it is vitally important here, with res...
I hope that the administration--I think, as you listen to the Members here--get a strong sense of the importance of--as ...
I think we have learned a lot of lessons over the past decade about the difference between unilateral action and multila...
